These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5833070)

  • 1. The action of protamine derivatives and nitrogen mustard on the growth of the Walker 256 rat carcinoma.
    Garvie WH
    Br J Cancer; 1965 Sep; 19(3):519-26. PubMed ID: 5833070
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the effects of cytotoxic agents on the Walker 256 tumour growing in the rat and at the hamster cheek pouch.
    Smith GM
    Br J Cancer; 1969 Mar; 23(1):88-94. PubMed ID: 5768448
    [No Abstract]   [Full Text] [Related]  

  • 3. DL-willardiine mustard.
    Martinez AP; Lee WW; Goodman L
    J Med Chem; 1968 Jan; 11(1):60-2. PubMed ID: 5637191
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on induced tumour resistance.
    Garvie WH
    Br J Surg; 1966 Jan; 53(1):69-73. PubMed ID: 5901917
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo.
    Sladek NE
    Cancer Res; 1973 Jun; 33(6):1150-8. PubMed ID: 4718666
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of aging aqueous nitrogen mustard on white blood cell count, body weight, and Walker 256 tumor in the rat.
    INCH WR; McCREDIE JA
    Can J Biochem Physiol; 1963 Feb; 41():417-25. PubMed ID: 13956469
    [No Abstract]   [Full Text] [Related]  

  • 7. Walker carcinosarcoma 256 in study of anticancer agents. II. Results.
    Everett J
    Cancer Res; 1966 Aug; 26(8 Pt 2):942-9. PubMed ID: 4224206
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental study of the antineoplastic effect of the antibiotic polymycin].
    Terent'eva TG; Fomina IP; Navashin SM
    Antibiotiki; 1970 May; 15(5):442-7. PubMed ID: 4988019
    [No Abstract]   [Full Text] [Related]  

  • 9. INTRALUMINAL CHEMOTHERAPY WITH NITROGEN MUSTARD IN SIMULATED CANCER OF THE COLON IN THE RAT.
    GROSSI CE; COLE DR; ROUSSELOT LM
    J Surg Res; 1964 Jul; 4():334-6. PubMed ID: 14214452
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of wound irrigation with nitrogen mustard or Clorpactin XCB on local recurrence of rat and mouse tumors.
    INCH WR; McCREDIE JA
    Cancer; 1963 May; 16():599-602. PubMed ID: 13956471
    [No Abstract]   [Full Text] [Related]  

  • 11. DESTRUCTION OF MALIGNANT CELLS IN PERITONEAL CAVITY. EXPERIMENTAL USE OF A CHEMOTHERAPEUTIC AGENT.
    MCKIBBIN B
    Arch Surg; 1964 Oct; 89():691-4. PubMed ID: 14186804
    [No Abstract]   [Full Text] [Related]  

  • 12. [RESEARCH ON THE ANTIBLASTIC ACTION OF A NITROGEN MUSTARD OF THE URETHANE TYPE BOUND TO HYDROCORTISONE].
    ZIMEL H; MACRINEANU A
    Stud Cercet Endocrinol; 1964; 15():413-8. PubMed ID: 14241419
    [No Abstract]   [Full Text] [Related]  

  • 13. Decrease in pulmonary metastases: potentiation of nitrogen mustard effect by heparin and fibrinolysin.
    AGOSTINO D; CLIFFTON EE
    Ann Surg; 1963 Mar; 157(3):400-8. PubMed ID: 14011261
    [No Abstract]   [Full Text] [Related]  

  • 14. COMPARATIVE RESPONSE OF A SPECTRUM OF TRANSPLANTABLE RAT NEOPLASMS TO NITROGEN MUSTARD, TRIETHYLENEMELAMINE, AND A GROUP OF BENZALDEHYDE MUSTARD DERIVATIVES.
    DUNNING WF; CURTIS MR
    Cancer Chemother Rep; 1964 Mar; 36():5-19. PubMed ID: 14152277
    [No Abstract]   [Full Text] [Related]  

  • 15. Selection of nitrogen mustard resistance in a rat tumor cell line results in loss of guanine-O6-alkyl transferase activity.
    Dean SW; Gibson NW; Tew KD
    Mol Pharmacol; 1986 Jul; 30(1):77-80. PubMed ID: 3724747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [INHIBITION OF THE RESPIRATORY ACTIVITY IN SOME EXPERIMENTAL TUMORS UNDER THE INFLUENCE OF NITROGEN MUSTARD].
    SANTORO M; CAPPELLI L
    Oncologia; 1964; 18():171-7. PubMed ID: 14220364
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth inhibitory and haematological effects of alkylating agents and attempts at their modification to give greater selectivity of anti-tumour action.
    Elson LA
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):51-9. PubMed ID: 5659736
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity of combinations of uracil mustard (NSC-34462) and 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) [KTS; NSC-82116] against murine tumors.
    Petering HG; Buskirk HH; Crim JA
    Cancer Chemother Rep; 1966 Nov; 50(8):557-64. PubMed ID: 5978728
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral activity of mitomycin C (NSC-26980) on Walker 256 (intramuscular) tumor.
    Bradner WT
    Cancer Chemother Rep; 1968 Apr; 52(3):389-91. PubMed ID: 5670720
    [No Abstract]   [Full Text] [Related]  

  • 20. POTENTIAL ANTICANCER AGENTS. IV. HETEROCYCLIC PHOSPHORAMIDE NITROGEN MUSTARDS.
    ZIMMER H; SILL AD
    Arzneimittelforschung; 1964 Feb; 14():150-1. PubMed ID: 14229652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.